Abate As Industries Limited has appointed Mr. Aboobaker Vattamkandathil as a Non-Executive Non-Independent Director. Additionally, the company announced the re-appointment and rotation status for other directors.
Abate AS Industries Limited conducted its 35th Annual General Meeting on September 16, 2026, via video conferencing. The meeting transacted key business items including director reappointments.
Abate AS Industries Limited informed shareholders who have not registered their email addresses about accessing the FY 2025-26 Annual Report and 35th AGM notice.
Abate AS Industries Limited has scheduled its 35th Annual General Meeting on September 16, 2026. The company also announced book closure and e-voting dates.
Abate AS Industries Limited has submitted its Annual Report for the Financial Year 2025-26, which includes the notice for its 35th Annual General Meeting.
Abate As Industries Ltd has scheduled a Board Meeting on 13th August 2026 to consider unaudited financial results for the quarter ended 30th June 2026.
Abate As Industries Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing details equity holdings across promoter and public categories.
Abate AS Industries corrected the format of its audited financial results auditor's report per BSE query. The correction has no financial impact on the previously filed results.
Abate AS Industries reported strong Q4 FY2026 results, highlighting a strategic transition from platform building to scaling, driven by its healthcare segment expansion.
Abate As Industries reported audited standalone and consolidated financial results for the year ended March 31, 2026. The board also appointed new internal auditors.
Abate As Industries Limited submitted its Annual Secretarial Compliance Report for the financial year 2026. The report by Lakshmmi Subramanian & Associates confirms regulatory compliance for shareholders.
Abate As Industries scheduled a board meeting for May 29, 2026, to approve audited FY26 financial results. The trading window remains closed until 48 hours post-meeting.
Abate As Industries appointed Mr. Harikumar V as an Independent Director effective February 12, 2026. The move strengthens the board with seasoned technical leadership expertise.
Abate As Industries announced postal ballot results for appointing Mr. Harikumar V as Independent Director. Shareholders approved the special resolution with 99.99% majority support.
NPMED Healthcare LLP, a non-promoter entity, sold 2,26,03,900 shares (14.34% stake) of Abate As Industries Limited through the open market. Following the disposal, the seller's holding reduced from 24.43% to 10.09%.
Abate As Industries Ltd confirmed it is not identified as a Large Corporate for FY 2025-26 under SEBI's debt security framework. The company reported outstanding borrowings of ₹1.58 Crore as of March 31, 2026. This is a routine regulatory compliance filing regarding fund-raising requirements for large entities.
Abate As Industries Limited has issued a postal ballot notice to seek shareholder approval for the appointment of Mr. Harikumar V as an Independent Director for a five-year term. The e-voting period runs from April 10 to May 9, 2026, with results expected by May 12, 2026.
Abate As Industries Ltd has approved the regularization of Mr. Harikumar V as an Independent Director for a five-year term, effective from February 12, 2026. The appointment is subject to shareholder approval via postal ballot. Mr. Harikumar brings 35 years of experience in manufacturing operations and sales.